Skip to content

Clinical trials

Withdrawn Phase 1/2 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Withdrawn Country / region: South Korea Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20151
20161
20191
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Artiva Biotherapeutics, Inc.1
Bayer1
Celgene1
Genexine, Inc.1
Helixmith Co., Ltd.1
Merck Sharp & Dohme LLC1
Yae-Jean Kim1
Yooyoung Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms1
Cytomegalovirus Infections1
Granulomatous Disease, Chronic1
Lymphoma, B-Cell1
Multiple Myeloma1
Neoplasm Metastasis1
Osteoarthritis1
Osteoarthritis, Knee1
Stomach Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.